- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00059683
Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women
Vaginal Ultrasound Cerclage Trial
Study Overview
Detailed Description
Women with a prior early spontaneous preterm birth and a shortened mid-trimester cervical length (less than 25 mm) are at very high risk for having another premature baby. The Vaginal Ultrasound Cerclage Trial is a multicenter, randomized clinical trial designed to determine the efficacy of cerclage (a purse-string suture placed around the uterine cervix) for the prevention of spontaneous preterm birth prior to 35 weeks' gestation. The study will evaluate women at significant risk for recurrent spontaneous preterm birth (those with a prior spontaneous birth at 17 to 32 weeks' gestation) and who have an increased risk based on mid-trimester ultrasound findings of a cervical length less than 25 mm.
The trial will have an observational portion and an interventional portion. In the observational portion, 1,000 women with a history of a spontaneous preterm birth at 17 to 32 weeks' gestation will undergo biweekly vaginal ultrasounds beginning at 16 to 18 weeks' gestation and ending by 22 weeks. Prior research indicates that one third of these women will either have or develop a cervix less than 25 mm long. Women will be seen at a frequency determined by the cervical length (as determined by ultrasound examination starting at 16 weeks' gestation). If cervical length remains greater than 30 mm, the next visits will occur in 2 week intervals until 22.6 weeks' gestation. If the cervical length is 25 mm to 29 mm, the visits will be scheduled weekly. If the cervical length shortens to less than 25 mm, the woman is eligible for randomization, and will undergo one more study visit.
In the interventional portion of the trial, women will be randomized to either cerclage or no cerclage (control group). Randomized women will have weekly contact with a nurse either by phone or in person, whichever is convenient for the woman, until delivery occurs. The woman is followed during the course of her pregnancy and delivery of her infant. Her infant is followed until discharge from the hospital.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35249
- University of Alabama at Birmingham
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Pregnant with a singleton gestation
- History of at least 1 prior spontaneous preterm birth at or before 32 weeks' gestation
Exclusion Criteria
- Cervical cerclage planned for this pregnancy
- Clinical history of cervical incompetence
- Untreated C. trachomatis or N. gonorrhoeae infection or symptomatic vaginitis
- Unable to obtain mid-trimester ultrasound to confirm no major fetal anomaly (i.e., aneuploidy, major organ system defect) or fetal demise prior to enrollment
- Multiple gestation
- Prolapsed or ruptured membranes noted on initial speculum examination
- Cervical os dilation > 2 cm noted on initial speculum examination
- Oligohydramnios
- Complete placenta previa
- Chronic hypertension or vascular disease requiring therapy
- Maternal red cell alloimmunization
- Insulin dependent diabetes
- Significant renal or cardiopulmonary disease
- Delivery or prenatal care outside clinical center
- Enrolled in this study in a previous pregnancy
- Participation in a randomized trial with interventions or endpoints in conflict with the cerclage randomized trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Cervical Cerclage Group
Women randomized to receive cerclage should receive cervical cerclage
|
Cerclage is a circumferential stitch of non-absorbable suture placed around the cervix
|
|
NO_INTERVENTION: Control Group
Women randomized to not receive cerclage represent the control arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Incidence of preterm birth less than 35 weeks' gestation
Time Frame: Birth
|
Birth
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Gestational age at birth
Time Frame: birth
|
birth
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: John Owen, MD, University of Alabama at Birmingham
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- U01HD039939-01A1 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor, Premature
-
Assistance Publique Hopitaux De MarseilleUnknownPremature LabourFrance
-
The University of Texas Medical Branch, GalvestonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPremature Birth | Pregnancy | Premature LaborUnited States
-
Ferring PharmaceuticalsCompletedPremature Birth | Labor, PrematureFinland, Belgium, Czech Republic, Lithuania, Poland, Romania
-
GlaxoSmithKlineCompletedObstetric Labour, Premature | Premature LaborUnited States
-
Hospital Clinic of BarcelonaCompletedThreatened Premature LaborSpain
-
Mohamed Sayed AbdelhafezRecruiting
-
University of CincinnatiUniversity HospitalTerminatedPremature Birth | Premature LaborUnited States
-
State University of New York at BuffaloCompleted
-
NYU Langone HealthWithdrawnPremature Birth | Premature LaborUnited States
-
Yale UniversityWithdrawnPremature Birth | Premature Labor
Clinical Trials on cervical cerclage
-
Zagazig UniversityRecruitingPreterm Birth | Twin Pregnancy, Antepartum Condition or Complication | Cervical CerclageEgypt
-
Zagazig UniversityCompletedPreterm Birth | Twin Pregnancy With Antenatal Problem | Cervical ShorteningEgypt
-
Rambam Health Care CampusUnknown
-
Maternal-Infantil Vall d´Hebron HospitalCompletedCervical InsufficiencySpain
-
St George's, University of LondonUnknownPreterm Birth | Twin Pregnancy With Antenatal Problem | Twin to Twin Transfusion SyndromeUnited Kingdom
-
Obstetrix Medical GroupTerminatedFetal Membranes, Premature RuptureUnited States
-
Thomas Jefferson UniversityRecruiting
-
Ningbo UniversityThe Affiliated Ningbo Women and Children's Hospital of Ningbo University; Yinzhou...Not yet recruiting
-
Thomas Jefferson UniversityFederico II UniversityRecruitingPreterm Birth | Twin Pregnancy With Antenatal Problem | Short CervixUnited States, Egypt, Italy, Spain
-
Benha UniversityCompleted